Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Alector Inc (ALEC)

Alector Inc (ALEC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Alector Inc 131 OYSTER POINT BLVD. SUITE 600 SOUTH SAN FRANCISCO CA 94080 USA

www.alector.com Employees: 244 P: 415-231-5660

Description:

Alector Inc. is a clinical stage biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegenerative diseases. Its product portfolio includes AL001, AL101, Al002 and AL003 which are in clinical stage. Alector Inc. is headquartered in South San Francisco, California.

Key Statistics

Overview:

Market Capitalization, $K 182,155
Enterprise Value, $K 107,595
Shares Outstanding, K 97,933
Annual Sales, $ 97,060 K
Annual Net Income, $ -130,390 K
Last Quarter Sales, $ 15,340 K
Last Quarter Net Income, $ -42,220 K
EBIT, $ -185,200 K
EBITDA, $ -191,670 K
60-Month Beta 0.51
% of Insider Shareholders 9.10%
% of Institutional Shareholders 85.83%
Float, K 89,021
% Float 90.90%
Short Volume Ratio 0.46

Growth:

1-Year Return -76.40%
3-Year Return -92.16%
5-Year Return -89.43%
5-Year Revenue Growth 250.65%
5-Year Earnings Growth 66.23%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.43 on 11/06/24
Next Earnings Date 11/05/24
Earnings Per Share ttm -1.70
EPS Growth vs. Prev Qtr -7.50%
EPS Growth vs. Prev Year 18.87%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ALEC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -108.77%
Return-on-Assets % -27.03%
Profit Margin % -134.34%
Debt/Equity 0.00
Price/Sales 1.80
Price/Cash Flow N/A
Price/Book 1.46
Book Value/Share 1.22
Interest Coverage -1.21
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar